Illustration of throat with glowing light and plant roots around stomach symbolizing combined treatment for globus pharyngeus

Struggling with That Lump-in-Your-Throat Feeling? Relief May Be Closer Than You Think

"Innovative Combination Therapy Offers New Hope for Globus Pharyngeus Sufferers"


That persistent sensation of a lump or foreign object lodged in your throat, even when nothing is there? You're likely experiencing Globus Pharyngeus (GP), a frustratingly common complaint that brings many to the otolaryngologist's office. Often linked to laryngopharyngeal reflux disease (LPRD), GP can significantly impact your daily comfort and quality of life.

Proton pump inhibitors (PPIs) have become a go-to treatment for LPRD, aiming to reduce stomach acid and ease symptoms, but relief isn't always guaranteed. Traditional Japanese medicine offers another avenue. Rikkunshito, known for its prokinetic effects that stimulate gastrointestinal movement, has shown promise in managing gastroesophageal reflux disease (GERD) symptoms. The big question is can these be combined?

Now, a new study investigates the combined power of high-dose PPIs and rikkunshito for GP sufferers. By exploring this innovative approach, we aim to shed light on the potential for a more effective treatment strategy, especially for those who find PPIs alone aren't enough.

AI Search Multiple angles on this topic

A Common Yet Under-Measured Symptom

Globus pharyngeus — the sensation of a lump in the throat with no physical obstruction — is a surprisingly common complaint, though reliable population figures vary across studies and settings. Many cases resolve on their own, while others persist for months or years. Because the condition overlaps with reflux, anxiety, and other factors, its true impact on health-care use and quality of life is difficult to pin down precisely.

An Illness Without a Standard Playbook

Globus is a persistent or intermittent, non-painful sensation of a lump or foreign body in the throat — a commonly encountered clinical condition that is usually long-lasting, difficult to treat, and has a tendency to recur. Because so little is known about its etiology, causes remain controversial and no standard investigation or treatment strategy has been established. Investigation and management are widely variable, and most tests yield negative results while still incurring patient morbidity and health-care costs, with malignancy vanishingly rare in the absence of red flag symptoms and ear, nose and throat examination findings. Notably, reassurance and clinical attention yielded symptom reduction comparable to active interventions, while partial epiglottectomy in refractory patients with epiglottic–tongue base contact was linked to symptom resolution only in small uncontrolled series.

A Long-Held Complaint, A Shifting Explanation

The sense of a lump in the throat has been noted by clinicians for many decades, and it appears under several older names in the medical literature. Early explanations tended to emphasize emotional causes, while modern understanding sees the symptom as complex and spanning multiple body systems. The precise milestones of that evolution are not documented in the sources used for this section, so no specific dates or landmark studies can be cited here.

Unlocking the Potential: PPIs and Rikkunshito for GP Relief

Illustration of throat with glowing light and plant roots around stomach symbolizing combined treatment for globus pharyngeus

The study, published in the Journal of Medical Investigation, enrolled 106 patients struggling with GP, none of whom had any visible organic causes identified through endoscopic examination. The research team embarked on a two-step treatment process. Initially, all participants were given high-dose PPIs for a period of 4 to 8 weeks.

The initial results were encouraging: Roughly 61% of the patients experienced significant improvement in their GP symptoms with PPI treatment alone. For the remaining 41 patients who didn't respond to PPIs, the study took an interesting turn.

  • A subset of these PPI-refractory patients (22 individuals) were then treated with a combination of high-dose PPIs and rikkunshito.
  • The results demonstrated that roughly 63% of these patients experienced a notable reduction in their GP symptoms after four weeks.
  • The study emphasizes the existence of LPRD in those complaining about GP.
AI Search Multiple angles on this topic

Newer Evidence Points to a Multimodal Path

Recent otorhinolaryngology literature continues to describe globus pharyngeus as a diagnostic dilemma and one of the common symptoms for which patients are referred to ENT clinics, with causes varying according to the region of involvement along the upper aero-digestive tract. One recent review notes that globus affects up to 45.6% of healthy adults in community-based studies and accounts for about 4% of all consultations in otorhinolaryngology departments, attributing its unclear, multifactorial etiology in part to reflux diseases and psychological factors. The British Journal of General Practice points out that the word 'globus' is Latin for globe or ball and that patients often describe the sensation as a frog, hair, phlegm, or catarrh stuck in the throat, typically worse on a dry or empty swallow with no physical obstruction or actual dysphagia. Recommended treatment is a multimodal approach that prioritizes CBT-based psychoeducation and speech-language therapy, with neuromodulators such as SSRIs or low-dose amitriptyline considered for refractory cases, while proton pump inhibitors show limited benefit. Throughout, detailed history and examination remain essential, and reassurance is described as a key component of management.

What the Literature Can't Yet Explain

The reviews examined here describe globus in consistent, heavily hedged terms: a persistent or intermittent, non-painful sensation of a lump or foreign body in the throat that frequently improves with eating. One 2012 review illustrates the difficulty through the case of an operatic tenor who presented to therapy with globus, underscoring that even skilled professionals can struggle to find a clear diagnosis or durable cure. Rather than documenting a single decisive failure or refuted theory, the sources highlight the absence of any unified explanation, with stubborn limitations in treatment rooted in the condition's unknown cause. What the literature consistently supports is that globus is common, tenacious, and resistant to simple classification.

Comparing Approaches: A Gap in the Evidence

A formal head-to-head comparison of the management options for globus pharyngeus would be valuable, since clinicians must choose among behavioral therapy, speech-language therapy, medication, and occasional surgical approaches. However, no directly comparative sources were available for this section, so a rigorous comparative analysis cannot be offered here without risking unsupported claims. Readers should therefore treat any informal comparisons of treatments with caution and defer to clinical guidance in individual cases.

This suggests that, in addition to acid reflux, disrupted gastrointestinal motility may play a crucial role in the development of GP.

A Combined Approach: The Future of GP Treatment?

This research shines a light on the complexity of Globus Pharyngeus and suggests that effective treatment may require addressing more than just acid reflux. The promising results of combining PPIs with rikkunshito open new avenues for those seeking relief from this bothersome condition.

AI Search Multiple angles on this topic

Experts Converge: Common, Benign, and Underserved

Expert reviews agree that globus pharyngeus is a common, persistent or intermittent, painless foreign-body sensation in the throat that represents around 4% of ENT referrals from primary care. The aetiology of the condition is poorly understood, and there is currently no universally accepted investigation pathway or treatment approach. Despite being generally benign, globus has limited treatment options, which has prompted researchers to evaluate interventions such as transcutaneous auricular vagus nerve stimulation (taVNS). Major centers, including UCLA Health's Robert G. Kardashian Center for Esophageal Health, continue to offer expert diagnosis and treatment for the condition.

A Reassuring Trajectory With Targeted Care

Looking ahead, the outlook for globus is generally reassuring: the Cleveland Clinic notes that the sensation often resolves on its own, though some people will need treatment to correct it. Because globus is a symptom of several different conditions — including GERD, postnasal drip, and thyroid disease — future progress depends on identifying and addressing the underlying driver in each patient. Practical guidance continues to emphasize understanding what causes the feeling, recognizing when to see a doctor, and knowing how the condition is typically treated.

Systemic Hurdles in Care Delivery

Placing globus pharyngeus in a broader systems context is difficult with the materials reviewed here, because none of the sources provided for this section covered systemic or policy-level challenges directly. Still, themes running through the wider literature — variable investigation practices, low-yield diagnostics, and care that is split across ENT, gastroenterology, and psychological services — suggest real-world inefficiencies. These observations should be read as general commentary rather than documented findings.

When Everyday Symptoms Become Overwhelming

A case from Frontline Gastroenterology illustrates the experience: a 47-year-old woman felt a lump in her throat for a year, intermittently, usually improving when she ate but worse with dry swallows, when it felt like a tablet was stuck; the sensation became more persistent in recent weeks and led her to worry that she had cancer, despite having no cough or sore throat. That fear is understandable given how persistent and intrusive the symptom can become. In another case, reported as the first in the English literature of cervical plexus block being used for globus, the block provided immediate relief to a patient who had been refractory to a multitude of traditionally used mainstay interventions.

If you're experiencing a persistent lump-in-your-throat sensation, it's essential to consult with an otolaryngologist to determine the underlying cause. Discussing the potential benefits of both PPI therapy and alternative approaches like rikkunshito could be a crucial step towards finding the right solution for you.

While the study offers hope, it's important to remember that individual results may vary. Further research is needed to fully understand the mechanisms behind rikkunshito's effects and to identify which patients are most likely to benefit from this combined therapy. But for now, it's a promising step forward in the quest to conquer Globus Pharyngeus.

Limits of this globus treatment study

  • The combination phase included only patients who chose further treatment; others who declined dropped out, which may have shaped the treated group.[1]

A sequential trial of PPI alone and rikkunshito add-on therapy

PopulationPatients complaining of globus pharyngeus without organic endoscopic findings[2]
Sample size106[2]
Duration4 to 8 weeks of high-dose PPI alone; 4 weeks of combination treatment[2]
ComparisonHigh-dose PPI alone[2]
Effect sizeSymptoms improved in 65 patients after high-dose PPI alone and in 14 of 22 patients after combination treatment[2]
Times cited7[2]

Questions the globus findings leave open

  • Would the combination produce the same pattern of improvement if compared directly with continued PPI alone in the refractory group?[2]
  • Can pretreatment symptoms or endoscopic features identify patients more likely to respond, given that these features did not predict efficacy in this study?[2]

Terms used in the study

gastroesophageal clearance
The passage describes this as a process enhanced by rikkunshito.[1]

Sources

  1. Sei-ichi Nakano (www.jstage.jst.go.jp)
  2. Efficacy of proton pump inhibitor in combination with rikkunshito in patients complaining of globus pharyngeus (University of Tokushima Faculty of Medicine, 2016)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.2152/jmi.63.227, Alternate LINK

Title: Efficacy Of Proton Pump Inhibitor In Combination With Rikkunshito In Patients Complaining Of Globus Pharyngeus

Subject: General Biochemistry, Genetics and Molecular Biology

Journal: The Journal of Medical Investigation

Publisher: University of Tokushima Faculty of Medicine

Authors: Sei-Ichi Nakano, Hidetaka Iwasaki, Eiji Kondo, Katsushi Miyazaki, Haruhiko Shizuku, Sei-Ichiro Kamimura, Junya Fukuda, Ryo Kanamura, Noriaki Takeda

Published: 2016-01-01

Everything You Need To Know

1

What exactly is Globus Pharyngeus (GP), and how does it affect daily life?

Globus Pharyngeus (GP) is that recurring feeling of having a lump or something stuck in your throat, even when there's nothing physically there. It's a common reason people visit ear, nose, and throat doctors. Laryngopharyngeal reflux disease (LPRD) is often associated with it and can really impact your day-to-day comfort.

2

What role do proton pump inhibitors (PPIs) and rikkunshito play in treating Globus Pharyngeus (GP)?

Proton pump inhibitors (PPIs) are frequently used to treat LPRD by reducing stomach acid. However, a traditional Japanese medicine called rikkunshito, which enhances gastrointestinal movement, has also been shown to help with gastroesophageal reflux disease (GERD) symptoms. The study looks at combining the two in treatment.

3

How was the study conducted, and what were the main results of combining PPIs and rikkunshito for Globus Pharyngeus (GP) sufferers?

The study, which was written about in the Journal of Medical Investigation, divided 106 patients with GP into two stages of treatment. The patients who did not get better with PPIs were given high doses of PPIs in conjunction with rikkunshito. Following this combined treatment, about 63% of these individuals reported a noticeable improvement in their symptoms.

4

What does the study suggest about the underlying causes of Globus Pharyngeus (GP)?

The findings imply that disrupted gastrointestinal motility, in addition to acid reflux, may be a significant role in the development of Globus Pharyngeus (GP). This suggests that treating GP may require addressing multiple underlying issues, rather than just focusing on acid reduction alone. More specifically, LPRD is found to have a correlation with GP complaints.

5

What are the broader implications of these findings for treating Globus Pharyngeus (GP), and what further research is needed?

The study found that a combination of PPIs and rikkunshito had promising results in reducing GP symptoms, especially for those who didn't find relief with PPIs alone. This suggests that a more comprehensive approach, addressing both acid reflux and gastrointestinal motility, could be the future of effectively managing this condition. However, further research is needed to fully understand the long-term benefits and optimal usage of this combined therapy, as well as to identify which specific patient profiles would benefit most from it. Future studies could also explore other potential contributing factors to GP, such as stress and muscle tension, to develop even more targeted and effective treatments.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.